These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2414368

  • 1. Epidermal cell-derived thymocyte activating factor (ETAF) is a potent T-cell chemoattractant.
    Sauder DN, Monick MM, Hunninghake GW.
    J Invest Dermatol; 1985 Nov; 85(5):431-3. PubMed ID: 2414368
    [Abstract] [Full Text] [Related]

  • 2. Biologic properties of epidermal cell thymocyte-activating factor (ETAF).
    Sauder DN.
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):176s-179s. PubMed ID: 3874245
    [Abstract] [Full Text] [Related]

  • 3. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
    Luger TA, Sztein MB, Schmidt JA, Murphy P, Grabner G, Oppenheim JJ.
    Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
    [Abstract] [Full Text] [Related]

  • 4. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma.
    Tron VA, Rosenthal D, Sauder DN.
    J Invest Dermatol; 1988 Mar; 90(3):378-81. PubMed ID: 3279133
    [Abstract] [Full Text] [Related]

  • 5. Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF) by cultured keratinocytes.
    Kupper TS, McGuire J.
    J Invest Dermatol; 1986 Nov; 87(5):570-3. PubMed ID: 3534102
    [Abstract] [Full Text] [Related]

  • 6. Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging.
    Sauder DN, Stanulis-Praeger BM, Gilchrest BA.
    Arch Dermatol Res; 1988 Nov; 280(2):71-6. PubMed ID: 3260767
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line.
    Luger TA, Stadler BM, Luger BM, Sztein MB, Schmidt JA, Hawley-Nelson P, Grabner G, Oppenheim JJ.
    J Invest Dermatol; 1983 Sep; 81(3):187-93. PubMed ID: 6604110
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.
    Luger TA, Charon JA, Colot M, Micksche M, Oppenheim JJ.
    J Immunol; 1983 Aug; 131(2):816-20. PubMed ID: 6602848
    [Abstract] [Full Text] [Related]

  • 10. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).
    Luger TA, Stadler BM, Katz SI, Oppenheim JJ.
    J Immunol; 1981 Oct; 127(4):1493-8. PubMed ID: 6974195
    [Abstract] [Full Text] [Related]

  • 11. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.
    Gahring LC, Buckley A, Daynes RA.
    J Clin Invest; 1985 Oct; 76(4):1585-91. PubMed ID: 2997285
    [Abstract] [Full Text] [Related]

  • 12. Epidermal cell thymocyte activity factor/interleukin 1 (ETAF/IL)-like activity in lymph drained from normal human skin.
    Olszewski WL, Grzelak I, Ziolkowska A, Engeset A.
    Lymphology; 1988 Jun; 21(2):118-23. PubMed ID: 3265464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.
    Sauder DN, Mounessa NL, Katz SI, Dinarello CA, Gallin JI.
    J Immunol; 1984 Feb; 132(2):828-32. PubMed ID: 6361134
    [Abstract] [Full Text] [Related]

  • 16. Role of epidermal cell thymocyte-activating factor in the proliferation and differentiation of murine B cells.
    Pillai PS, Reynolds SD, Scott DW, Gauldie J, Sauder DN.
    J Leukoc Biol; 1987 Sep; 42(3):222-9. PubMed ID: 3305747
    [Abstract] [Full Text] [Related]

  • 17. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB, Abdel-Malek ZA, Sauder DN, Nordlund JJ.
    J Immunol; 1989 Mar 15; 142(6):1943-9. PubMed ID: 2466081
    [Abstract] [Full Text] [Related]

  • 18. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF).
    Breathnach SM, Katz SI.
    J Invest Dermatol; 1985 Dec 15; 85(6):553-8. PubMed ID: 3877770
    [Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide.
    Pignol B, Lonchampt MO, Chabrier PE, Mencia-Huerta JM, Braquet P.
    J Lipid Mediat; 1990 Dec 15; 2 Suppl():S83-91. PubMed ID: 2133287
    [Abstract] [Full Text] [Related]

  • 20. Epidermal cell thymocyte-activating factor.
    Sauder DN.
    Adv Dermatol; 1986 Dec 15; 1():237-46. PubMed ID: 3079245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.